Separating ELA from the Crowd
Article May 31, 2011
From Left to Right: Professor Karl-Siegfried Boos, University of Munich; Professor Hans Maurer, Saarland University; Professor M. Arthur Moseley, Duke University.
Integrating perfectly within ELA, AST will provide delegates an opportunity, unique in Europe, to discuss technique and technology advancements which enhance the separations workflow and productivity. AST will bring together a long list of respected academic faculty members and leading vendors. Hot topics under discussion at the conference will include:
• Novel Separation Techniques and Methodologies
• Small Molecule Applications
• Separation Science for Mass Spectrometry
• Protein Analysis
• Trapped Ions
Select Biosciences have arranged the highest calibre keynote speakers for all ELA conference streams. AST will be addressed by Professor Karl-Siegfried Boos from the University of Munich, who will discuss “Automated Processing of Native Biofluids Up-Front to LC-MS/MS Analysis of Small Molecules”; Professor Hans Maurer of Saarland University, who will present a talk entitled "Current Role of Hyphenated Low and High Resolution Mass Spectrometry in Clinical and Forensic Toxicology"; and by Professor M. Arthur Moseley, Director of Proteomics at Duke University with a symposium on "Mass Spectrometry Based Translational Proteomics – From the Benchtop to the Bedside".
To complement and enhance the discussion around the development in separations techniques and technology, key companies will present free lunch time workshops highlighting their strategic advancements in separations technology. Dr. Ruediger Salowsky from Agilent Technologies will present on “Improving speed and automation of library QC in the next-gen sequencing workflow” on 30 June; Dr Stefan Kubicek from Perkin Elmer will present “High Content Screening for Compounds and Genes Affecting Bacterial and Viral Infections”, also on 30 June; and finally Dr Kevin Wood from Promega will present “Glosensor Technology: Intracellular Biosensors to Detect Signal Transduction in Living Cells” on 1 July.
To find out more about what ELA has to offer scientists across the board, please email firstname.lastname@example.org or visit www.EuroLabAutomation.com.
Advancing Drug Discovery Through Academic–Industry CollaborationArticle
Genestack recently announced that they were joining the Milner Therapeutics Institute. In light of the announcement, we spoke to Prof. Tony Kouzarides, Director of the Milner Therapeutics Institute and Dr. Misha Kapushesky, Founder and CEO of Genestack, to learn more.READ MORE
Lipidomics Opens Doors to Understanding Stem Cell DifferentiationArticle
It has long been known that the fats we consume in our diet can have an impact on our health. However, their implications on cell differentiation has not previously been understood. We spoke to Professor Ilya Levental about his group's exciting work in this field, the role of lipidomics and how this may affect the future of healthcare.READ MORE